{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:07:22Z","timestamp":1778720842587,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":17,"publisher":"Springer US","isbn-type":[{"value":"9781071650554","type":"print"},{"value":"9781071650561","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5056-1_6","type":"book-chapter","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:09:27Z","timestamp":1778717367000},"page":"59-74","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fragment Screening of MIF by Surface Plasmon Resonance"],"prefix":"10.1007","author":[{"given":"Emmanuel K.","family":"Yeboah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie A.","family":"Borg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Headey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"6_CR1","doi-asserted-by":"publisher","first-page":"30653","DOI":"10.1074\/jbc.M112.385583","volume":"287","author":"F Bai","year":"2012","unstructured":"Bai F, Asojo OA, Cirillo P et al (2012) A novel allosteric inhibitor of macrophage migration inhibitory factor (MIF). J Biol Chem 287:30653\u201330663","journal-title":"J Biol Chem"},{"key":"6_CR2","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3389\/fimmu.2015.00577","volume":"6","author":"T Lang","year":"2015","unstructured":"Lang T, Foote A, Lee JP et al (2015) MIF: implications in the pathoetiology of systemic lupus erythematosus. Front Immunol 6:577","journal-title":"Front Immunol"},{"key":"6_CR3","doi-asserted-by":"publisher","first-page":"108024","DOI":"10.1016\/j.pharmthera.2021.108024","volume":"233","author":"K Sumaiya","year":"2022","unstructured":"Sumaiya K, Langford D, Natarajaseenivasan K et al (2022) Macrophage migration inhibitory factor (MIF): a multifaceted cytokine regulated by genetic and physiological strategies. Pharmacol Ther 233:108024","journal-title":"Pharmacol Ther"},{"key":"6_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2174\/187152807781696455","volume":"6","author":"AY Hoi","year":"2007","unstructured":"Hoi AY, Iskander MN, Morand EF (2007) Macrophage migration inhibitory factor: a therapeutic target across inflammatory diseases. Inflamm Allergy Drug Targets 6:183\u2013190","journal-title":"Inflamm Allergy Drug Targets"},{"key":"6_CR5","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1093\/carcin\/bgt239","volume":"34","author":"S Choudhary","year":"2013","unstructured":"Choudhary S, Hegde P, Pruitt JR et al (2013) Macrophage migratory inhibitory factor promotes bladder cancer progression via increasing proliferation and angiogenesis. Carcinogenesis 34:2891\u20132899","journal-title":"Carcinogenesis"},{"key":"6_CR6","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/med.21385","volume":"36","author":"C O'Reilly","year":"2016","unstructured":"O\u2019Reilly C, Doroudian M, Mawhinney L et al (2016) Targeting MIF in cancer: therapeutic strategies, current developments, and future opportunities. Med Res Rev 36:440\u2013460","journal-title":"Med Res Rev"},{"key":"6_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02992-y","volume":"11","author":"M Charan","year":"2020","unstructured":"Charan M, Das S, Mishra S et al (2020) Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer. Cell Death Dis 11:774","journal-title":"Cell Death Dis"},{"key":"6_CR8","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1016\/j.drudis.2018.06.017","volume":"23","author":"T Kok","year":"2018","unstructured":"Kok T, Wasiel AA, Cool RH et al (2018) Small-molecule inhibitors of macrophage migration inhibitory factor (MIF) as an emerging class of therapeutics for immune disorders. Drug Discov Today 23:1910\u20131918","journal-title":"Drug Discov Today"},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"11313","DOI":"10.1073\/pnas.1002716107","volume":"107","author":"Y Cho","year":"2010","unstructured":"Cho Y, Crichlow GV, Vermeire JJ et al (2010) Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast. Proc Natl Acad Sci U S A 107:11313\u201311318","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR10","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1096\/fj.201701189R","volume":"32","author":"A Sparkes","year":"2018","unstructured":"Sparkes A, De Baetselier P, Brys L et al (2018) Novel half-life extended anti-MIF nanobodies protect against endotoxic shock. FASEB J 32:3411\u20133422","journal-title":"FASEB J"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1111\/bcp.14289","volume":"86","author":"D Mahalingam","year":"2020","unstructured":"Mahalingam D, Patel MR, Sachdev JC et al (2020) Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours. Br J Clin Pharmacol 86:1836\u20131848","journal-title":"Br J Clin Pharmacol"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1158\/1535-7163.MCT-12-0988","volume":"12","author":"F Hussain","year":"2013","unstructured":"Hussain F, Freissmuth M, Volkel D et al (2013) Human anti-macrophage migration inhibitory factor antibodies inhibit growth of human prostate cancer cells in vitro and in vivo. Mol Cancer Ther 12:1223\u20131234","journal-title":"Mol Cancer Ther"},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1177\/13524585231224702","volume":"30","author":"K Nakamura","year":"2024","unstructured":"Nakamura K, Thoomukuntla B, Bena J et al (2024) Ibudilast reduces slowly enlarging lesions in progressive multiple sclerosis. Mult Scler 30:369\u2013380","journal-title":"Mult Scler"},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.it.2019.03.002","volume":"40","author":"J Harris","year":"2019","unstructured":"Harris J, VanPatten S, Deen NS et al (2019) Rediscovering MIF: new tricks for an old cytokine. Trends Immunol 40:447\u2013462","journal-title":"Trends Immunol"},{"key":"6_CR15","volume-title":"Methods for fragments screening using surface plasmon resonance","author":"R Gosu","year":"2021","unstructured":"Gosu R, Zaheer S (2021) Introduction to surface plasmon resonance. In: Zaheer S, Gosu R (eds) Methods for fragments screening using surface plasmon resonance. Springer, Singapore"},{"key":"6_CR16","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.3390\/s22082901","volume":"22","author":"P Steglich","year":"2022","unstructured":"Steglich P, Lecci G, Mai A (2022) Surface plasmon resonance (SPR) spectroscopy and photonic integrated circuit (PIC) biosensors: a comparative review. Sensors (Basel) 22:2901","journal-title":"Sensors (Basel)"},{"key":"6_CR17","doi-asserted-by":"crossref","unstructured":"Van Cer Merwe P (2000) Surface plasmon reonance. In: Harding S, Chowdhry B (eds) Protein-ligand interacrtions: hydrodynamics and calorimetry. Oxford Academic","DOI":"10.1093\/oso\/9780199637492.003.0006"}],"container-title":["Methods in Molecular Biology","Macrophage Migration Inhibitory Factor"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5056-1_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:09:28Z","timestamp":1778717368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5056-1_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071650554","9781071650561"],"references-count":17,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5056-1_6","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 May 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this chapter.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}